“To enable patients to live an independent and active life without any impact of Alzheimer’s disease, by developing novel disease-modifying treatments.”
Our long-term goal
Our long-term goal is to develop a disease-modifying therapeutic vaccine for the treatment and prevention of the progression of Alzheimer’s disease. A long-acting drug will make it possible for patients to lead an active and independent life without impact from the disease.
Learn more about Alzheimer’s disease, our programs and the potential of our unique proprietary AβCC technology.
Learn more about the Alzinova portfolio and our proprietary AβCC Peptide™ Technology. Read more
Learn more about the causes of Alzheimer’s and the potential in our oligomer specific immunotherapy. Read more